Ancillotti, M., Erikson, S., Godskesen, T., Nihlen Fahlquist, J., Andersson, D. & Veldwijk, J. (2020). Preferences regarding antibiotic treatment and the role of antibiotic resistance: a discrete choice experiment. International Journal of Antimicrobial Agents, 56 (6). doi:

Ancillotti, M., Eriksson, S., Veldwijk, J., Nihlen Fahlquist, J., Andersson, D. & Godskesen, T. (2020). Public awareness and individual responsibility needed for judicious use of antibiotics: a qualitative study of public beliefs and perceptions. Bmc Public Health. doi:

Arslan, I.G., Huls, S.P.I., Bekker – Grob, E.W. de, Rozendaal, R.M., Bierma-Zeinstra, S.M.A. & Schiphof, D. (2020). Patients’, healthcare providers’, and health insurance employees’ preferences for knee and hip osteoarthritis care: a discrete choice experiment. The British journal of general practice : the journal of the Royal College of General Practitioners, 70 (suppl 1):bjgp20X711305. doi:

Arslan, I.G., Huls, S.P.I., Bekker – Grob, E.W. de, Rozendaal, R.M., Persoons, M.C.T., Hell, M.E. Spruijt-van, Bindels, P.J.E., Bierma-Zeinstra, S.M.A. & Schiphof, D. (2020). Patients’, healthcare providers’, and insurance company employees’ preferences for knee and hip osteoarthritis care: a discrete choice experiment. Osteoarthritis and Cartilage, 28 (10), 1316-1324. doi:

Baillon, A., Bleichrodt, H. & Spinu, V. (2020). Searching for the reference point. Management Science, 66 (1), 93-112. doi:

Bakker, L.J., Vaporidi, K., Aarts, J.E.C.M. & Redekop, W.K. (2020). The potential of real-time analytics to improve care for mechanically ventilated patients in the intensive care unit: an early economic evaluation. Cost Effectiveness and Resource Allocation. doi:

Beers, M. van, Rutten – van Molken, M.P.M.H., Bool, C. van de, Boland, M., Kremers, S.P.J., Franssen, F.M.E., Helvoort, A. van, Gosker, H.R., Wouters, E.F.M. & Schols, A.M.W.J. (2020). Clinical outcome and cost-effectiveness of a 1-year nutritional intervention programme in COPD patients with low muscle mass: The randomized controlled NUTRAIN trial. Clinical Nutrition, 39 (2), 405-413. doi:

Bekker – Grob, E.W. de, Donkers, B., Bliemer, M., Veldwijk, J. & Swait, J. (2020). Can healthcare choice be predicted using stated preference data? Social Science & Medicine, 246:112736. doi:

Blankenstein, S.A., Aarts, M., Berkmortel, F. van den, Boers-Sonderen, M., Eertwegh, A.J.M. Van den, Franken, M.G., Groot, J., Haanen, J., Hospers, G., Kapiteijn, E., Piersma, D., Rijn, R.S. van, Suijkerbuijk, K., Tije, A. ten, Veldt, A.A.M. van der, Vreugdenhil, G., Wouters, M. & Akkooi, A.C.J. (2020). Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy. Cancers, 12 (5). doi:

Bleichrodt, H., Doctor, J.N., Gao, Y., Li, C., Meeker, D. & Wakker, P.P. (2020). Resolving Rabin’s Paradox. Journal of Risk and Uncertainty, 59 (3), 239-260. doi:

Bremmers, L.G.M., Evers, S.M.A.A., Drost, R.M.W.A., Janssen, L.M.M., Pokhilenko, I. & Paulus, A. (2020). Intersectoral Costs and Benefits of Mental and Behavioural Disorders in the Education Sector: an Exploration of Costing Methods. The Journal of Mental Health Policy and Economics, 23 (4), 115-137.

Brugts, J.J., Veenis, J.F., Radhoe, S.P., LInsssen, G., Van Gent, M., Borleffs, C.J.W., van Ramhorst, J., van Pol, P., Tukkie, R., Spee, R., Emans, M., Kok, W., van Halm, V., Handoko, L., Beeres, S., Post, M., Boersma, E., Lenzen, M.J., Manintveld, O.C., Koffijberg, H., Baal, P.H.M. van, Versteegh, M.M., Smilde, T., van Heerebeek, L., Rienstra, M., Mosterd, A., Delnoy, P., Asselbergs, F.W., Brunner-La Rocca, H. & de Boer, R. (2020). A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure : Design and rationale of the MONITOR HF multicentre randomised clinical trial. Netherlands Heart Journal, 28 (1), 16-26. doi:

Chen, Y.H., Karimi, M. & Rutten-van Mölken, M.P.M.H. (2020). The disease burden of multimorbidity and its interaction with educational level. PLoS One (online). doi:

Cohen, A., Reijman, M., Kraan, G.A., Mathijssen, N.M.C., Koopmanschap, M.A., Verhaar, J.A.N., Mol, S. & Colaris, J.W. (2020). Clinically SUspected ScaPhoid fracturE: treatment with supportive bandage or CasT? ‘Study protocol of a multicenter randomized controlled trial’ (SUSPECT study). BMJ Open, 10 (9):e036998. doi:

Corro Ramos, I., Hoogendoorn – Lips, E.J.I. & Rutten – van Molken, M.P.M.H. (2020). How to Address Uncertainty in Health Economic Discrete-Event Simulation Models: An Illustration for Chronic Obstructive Pulmonary Disease. Medical Decision Making, 40, 619-632. doi:

Franken, M.G., Kanters, T.A., Coenen, J.L., De Jong, P., Jager, A. & Uyl – de Groot, C.A. (2020). Hospital-based or home-based administration of oncology drugs? A micro-costing study comparing healthcare and societal costs of hospital-based and home-based subcutaneous administration of trastuzumab. Breast, 52, 71-77. doi:

Goossens, L.M.A., Vemer, P. & Rutten – van Molken, M.P.M.H. (2020). A systematic review of hospital-at-home care: cost savings are overestimated. International Journal of Nursing Studies, 109:103652. doi:

Grigore, B., Ciani, O., Dams, F., Federici, C., Groot, S. de, Möllenkamp, M., Rabbe, S., Shatrov, K., Zemplenyi, A. & Taylor, R. (2020). Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines. Pharmacoeconomics (Print), 38, 1055-1070. doi:

Uyl – de Groot, C.A., Heine, R.J., Krol, H.M. & Verweij, J. (2020). Unequal Access to Newly Registered Cancer Drugs Leads to Potential Loss of Life-Years in Europe. Cancers, 12 (8), 1-17. doi:

Hoopen, L.W. ten, Nijs, P.F.A. de, Duvekot, J., Greaves-Lord, K., Hillegers, M.H.J., Brouwer, W.B.F. & Hakkaart – van Roijen, L. (2020). Children with an autism spectrum disorder and their caregivers: capturing health-related and care-related quality of life. Journal of Autism and Developmental Disorders, 49 (323), 1-15. doi:

Howe, S.E., Gerrits, T., Zulu, J.M. & Boivin, J. (2020). The social and cultural meanings of infertility for men and women in Zambia: legacy, family and divine intervention. Facts, views & vision in ObGyn, 12 (3).

Huls, S.P.I., Osch, S.M.C. van, Brouwer, W.B.F., Exel, N.J.A. van & Stiggelbout, A. (2020). Psychometric evaluation of the Health-Risk Attitude Scale (HRAS-13): assessing the reliability, dimensionality and validity in the general population and a patient population. Psychology and Health. doi:

Huygens, S.A., Ramos, I.C., Bouten, C., Kluin, J., Chiu, S.T., Grunkemeier, G.L., Takkenberg, J.J.M. & Rutten – van Molken, M.P.M.H. (2020). Early cost-utility analysis of tissue-engineered heart valves compared to bioprostheses in the aortic position in elderly patients. The European Journal Of Health Economics, 21 (4), 557-572. doi:

Jamal, M., Korver, A.M., Kuijper, M., Barreto, D., Appels, C.W.Y., Spoorenberg, A.P.L., Koes, B.W., Hazes, J.M.W., Hoeven, L. van & Weel, A.E.A.M. (2020). The IMPACT study: A clustered randomized controlled trial to assess the effect of a referral algorithm for axial spondyloarthritis. PLoS One (print), 15. doi:

Jonker, M., Bekker – Grob, E.W. de, Veldwijk, J., Goossens, L., Bour, S. & Rutten-van Mölken, M.P.M.H. (2020). COVID-19 Contact Tracing Apps: Predicted Uptake in the Netherlands Based on a Discrete Choice Experiment. Jmir Mhealth and Uhealth, 8 (10). doi:

Jonker, M.F., Donkers, B., Goossens, L., Hoefman, R., Jabbarian, L., Bekker – Grob, E.W. de, Versteegh, M., Harty, G. & Wong, S. (2020). Summarizing Patient Preferences for the Competitive Landscape of (Multiple Sclerosis) Treatment Options. Medical Decision Making, 40 (2), 198-211. doi:

Joode, K. de, Dumoulin, D.W., Tol, J., Westgeest, H.M., Beerepoot, L., Berkmortel, F.W.P. van den, Mutsaers, P.G.N.J., Diemen, N.G.J. van, Visser, O.J., Oomen-de Hoop, E., Bloemendal, H., Laarhoven, H. van, Hendriks, L.E.L., Haanen, J., Vries, E.G. de, Dingemans, A.C., Veldt, A.A.M. van der, Loenhout, C.J. van, Leest, K.H. van der, Becker-Commissaris, A., Borgers, J.S.W., Terhegggen, F., Borne, B. van den, Warmerdam, L.J.C. van, Leeuwen, L. van, Meer, F.S. van der, Tiemessen, M.A., Diepen, D.M. van, Klaver, Y., Hamberg, A.P., Libourel, E.J., Strobbe, L., Cloos, M., Geraedts, E.J., Drooger, JC, Heller, R., Groot, J.W.H. de, Stigt, J., Nuij, V.J.A.A., Pitz, C.C.M., Slingerland, M., Borm, F.J., Haberkorn, B.C.M., Westeinde, S.C.V., Aarts, M., Putten, J.W.G. van, Youssef, M., Cirkel, G., Herder, G.J., Rooijen, C.R. van, Citgez, E., Barlo, N.P., Scholtes, B.M.J., Koornstra, R.H., Claessens, N.J.M., Faber, L., Rikers, C.H., Wetering, R.A.W. van de, Veurink, G.L., Bouter, B.W., Houtenbos, I., Bard, M.P.L., Herbschleb, K.H., Kastelijn, E.A., Brocken, P., Douma, G., Jalving, M., Hiltermann, T.J.N., Schuurbiers-Siebers, O.C.J., Suijkerbuijk, K., Lindert, A.S.R. van, Wouw, A.J.V. de, Boogaart, V.E.M. van den, Bakker, S.D., Looysen, E., Peerdeman, A.L., Jong, W.K. de, Siemerink, E.J.M., Staal, A.J., Franken, B., Geffen, W.H. van & Bootsma, G.P. (2020). Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study. European Journal of Cancer, 141, 171-184. doi:

Kolasa, K., Redekop, W.K., Berler, A., Zah, V. & Asche, C.V. (2020). Future of data analytics in the era of the General Data Protection Regulation in Europe. Pharmacoeconomics (Print), 38 (10), 1021-1029. doi:

Krugten, F.C.W. van, Feltz-Cornelis, C.M. van der, Boeschoten, M.A., Broeckhuysen-Kloth, S.A.M., Eck van der Sluijs, J.F. van, Ee, E. van, Es, S.M. van, Schoorl, M., Tak, L.M., Brouwer, W.B.F. & Hakkaart-van Roijen, L. (2020). Development and psychometric evaluation of the Transdiagnostic Decision Tool: matched care for patients with a mental disorder in need of highly specialised care. Bjpsych Open, 6 (6). doi:

Kuppen, M.C.P., Westgeest, H.M., Eertwegh, A.J.M. Van den, Coenen, J., Moorselaar, R.J.A. van, Berg, P., Geenen, M.M., Mehra, N., Hendriks, M.P., Lampe, M.I., Luijtgaarden, A.C.M. van de, Peters, F.P.J., Roeleveld, T.A., Smilde, T., Wit, R. de, Oort, I. van, Gerritsen, W. & Groot, C.A. de (2020). Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the Netherlands. Clinical Genitourinary Cancer, 18 (3), E233-E253. doi:

Lambooij, M.S., Veldwijk, J., van Gils, P., Suijkerbuijk, A.W.M. & Struijs, J.N. (2020). Trading patients’ choice in providers for quality of maternity care? A discrete choice experiment amongst pregnant women. PLoS One (online). doi:

Leeneman, B., Groot, C.A. de, Aarts, M., Akkooi, A.C.J., Berkmortel, F. van den, Eertwegh, A.J.M. Van den, Groot, J. de, Herbschleb, K.H., Hoeven, J. van der, Hospers, G., Kapiteijn, E., Piersma, D., Rijn, R.S. van, Suijkerbuijk, K., Tije, A. ten, Veldt, A.A.M. van der, Vreugdenhil, G., Wouters, M., Haanen, J. & Franken, M.G. (2020). Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs. Cancers, 12 (4):1003. doi:

Lenk, E.J., Moungui, H.C., Boussinesq, M., Kamgno, J., Nana-Djeunga, H.C., Fitzpatrick, C., Peultier, A.M.M., Klion, A.D., Fletcher, D.A., Nutman, T.B., Pion, S.D., Niamsi-Emalio, Y., Redekop, W.K., Severens, J.L. & Stolk, W.A. (2020). A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa-coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon. Clinical Infectious Diseases, 70 (8), 1628-1635. doi:

Lugtenburg, P.J., Brown, P., Holt, B. van der, D’Amore, F.A., Koene, H.R., Jongh, E. de, Fijnheer, R., Esser, J. van, Bohmer, L.H., Pruijt, J.F.M., Verhoef, G., Hoogendoorn – Lips, E.J.I., Bilgin, M.Y., Nijland, M., Burg-de Graauw, N.C. van der, Oosterveld, M., Jie, K., Larsen, T.S., Poel, M.W.M. van der, Leijs, M.B., Silbermann, M.H., Kooy, M.V.M., Beeker, A., Kersten, M., Doorduijn, J.K., Tick, L.W., Brouwer, R., Lam, K.H., Burggraaff, C.N., Keizer, B. de, Arens, A., Jong, D. de, Hoekstra, O.S. & Zijlstra-Baalbergen, J.M. (2020). Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84). Journal of Clinical Oncology, 38 (29). doi:

Masurel, N., Weel, A.E.A.M., Hazes, J.M.W. & Jong, P.H.P. de (2020). Towards stratified treatment of rheumatoid arthritis. International Journal of Clinical Rheumatology (print), 15 (3), 73-82.

Luyendijk, M., Vernooij, R.W.M., Blommestein, H.M., Siesling, S. & Uyl-de Groot, C.A. de (2020). Assessment of Studies Evaluating Incremental Costs, Effectiveness, or Cost-Effectiveness of Systemic Therapies in Breast Cancer Based on Claims Data: A Systematic Review. Value in Health, 23 (11), 1497-1508. doi:

Meijer, E., Van Eeden, A.E., Kruis, A.L., Boland, M.R.S., Assendelft, W.J.J., Tsiachristas, A., Rutten – van Molken, M.P.M.H., Kasteleijn, E. & Chavannes, N. (2020). Exploring characteristics of COPD patients with clinical improvement after integrated disease management or usual care: post-hoc analysis of the RECODE study. BMC Pulmonary Medicine, 20. doi:

Molken, M.P.M.H. van, Karimi, M., Leijten, F.R.M., Hoedemakers, M.J., Looman, W.M., Islam, K., Askildsen, J.E., Kraus, M., ercevic, D., struckmann, V., Pitter, J.G., Cano, I., Stokes, J. & Jonker, M.F. (2020). Comparing patients’ and other stakeholders’ preferences for outcomes of integrated care for multimorbidity: a discrete choice experiment in eight European countries. BMJ Open. doi:

Mulligen, E. van, Weel, A.E.A.M., Hazes, J.M.W., Helm – van Mil, A.H.M. van der & Jong, P.H.P. de (2020). Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial. Annals of the Rheumatic Diseases, 79 (9), 1174-1181. doi:

Mulligen, E. van, Weel, A.E.A.M., Kuijper, T.M., Denissen, N.H.A.M., Gerards, A.H.M., Jager, M., Lam-Tse, W., Hazes, J.M.W., Helm – van Mil, A.H.M. van der, Jong, P.H.P. de & Luime, J.J. (2020). Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: Cost-utility analysis of the TARA trial. Annals of the Rheumatic Diseases, 79 (12), 1550-1556. doi:

Nijenhuis, V., Brouwer, J., Delewi, R., Hermanides, R.S., Holvoet, W., Dubois, C., Frambach, P., De Bruyne, B., van Houwelingen, G., Van Der Heyden, J., Toušek, P., van der Kley, F., Buysschaert, I., Schotborgh, C.E., Ferdinande, B., van der Harst, P., Roosen, J., Peper, J., Thielen, W.F., Veenstra, L., Chan Pin Yin, D., Swaans, M.J., Rensing, B.J.W.M., van ‘t Hof, A., Timmers, L., Kelder, J.C., Stella, P., Baan, J. & ten Berg, J. (2020). Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation. New England Journal of Medicine, 382 (18), 1696-1707. doi:

Peultier, A.M.M., Pandya, A., Sharma, R., Severens, J.L. & Redekop, W.K. (2020). Cost-effectiveness of Mechanical Thrombectomy More Than 6 Hours After Symptom Onset Among Patients With Acute Ischemic Stroke. Jama Network Open, 3 (8). doi:

Peultier, A.M.M., Venetsanos, D., Rashid, I., Severens, J.L. & Redekop, W.K. (2020). European survey on acute coronary syndrome diagnosis and revascularisation treatment: Assessing differences in reported clinical practice with a focus on strategies for specific patient cases. Journal of Evaluation in Clinical Practice, 26 (5), 1457-1466. doi:

Polak, T.B., Rosmalen, J.M. van & Groot, C.A. de (2020). Expanded Access as a source of real-world data: An overview of FDA and EMA approvals. British Journal of Clinical Pharmacology, 86 (9), 1819-1826. doi:

Polak, T.B., Rosmalen, J.M. van & Uyl-de Groot, C.A. de (2020). Response to Open Peer Commentary “Making It Count: Extracting Real World Data from Compassionate Use and Expanded Access Programs”. American Journal of Bioethics, 20 (11), W4-W5. doi:

Reckers – Droog, V.T., Goorden, M., Kaminer, Y. dr., van Domburgh, L., Brouwer, W.B.F. & Hakkaart-van Roijen, L. (2020). Presentation and validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): A preference-based measure for use in health-economic evaluations. PLoS One (online), 15 (9), 0-10. doi:

Schmid, S., Omlin, A., Higano, C., Sweeney, C., Chanza, N.M., Mehra, N., Kuppen, M.C.P., Beltran, H., Condeduca, V., Almeida, D.V.P. de, Maluf, F.C., Oh, W.K., Tsao, C.K., Sartor, O., Ledet, E., Lorenzo, G. Di, Yip, S.M., Chi, K.N., Bianchini, D., Giorgi, U. De, Hansen, A.R., Beer, T.M., Pernelle, L., Morales-Barrera, R., Tucci, M., Castro, E., Karalis, K., Bergman, A., Le, M.L., Zurrer-Hardi, U., Pezaro, C., Suzuki, H., Zivi, A., Klingbiel, D., Schar, S. & Gillessen, S. (2020). Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations. Jama Network Open, 3 (10). doi:

Singer, D.R.J., Redekop, W.K. & Cheung, B. (2020). Trusted writing in social media: FPM international awards for medical writing in social media. Postgraduate Medical Journal, 96 (1134), 183-183. doi:

Singer, D.R.J. & Redekop, W.K. (2020). What is ahead for health policy and technology in the 2020s? Health Policy and Technology, 9 (1), 3-4. doi:

Smit, L., Trogrlic, Z., Devlin, J.W., Osse, R.J., Ponssen, H., Slooter, A.J.C., Hunfeld, N.G.M., Rietdijk, W.J.R., Gommers, D.A.M.P.J., Jagt, M. van der, Boogaard, M., Brouwers, A., Lens, J.A., Meer, B.J.M. van der, Schoonderbeek, F.J., Simons, K.S., Berger, E., Bouman, A., Campo, M. Del, Duijn, D. van, Embden-van Donk, H., Graaf, D. de, Hoogendoorn, E., Ormskerk, P.M., Roovers, N., Toscano, E., Vileito, A., Zuylen, T. van, Exler, C.P., Berg, E. van den, Meeteren, J. van & Koopmanschap, M.A. (2020). Efficacy of halopeRIdol to decrease the burden of Delirium In adult Critically ill patiEnts (EuRIDICE): study protocol for a prospective randomised multi-centre double-blind placebo-controlled clinical trial in the Netherlands. BMJ Open, 10 (9):e036735. doi:

Thielen, W.F., Houwing, M.E., Cnossen, M.H., Hadithy-Irgiztseva, I.A. al, Hazelzet, J.A., Uyl – de Groot, C.A., Pagter, P.J. de & Blommestein, H.M. (2020). Cost of health care for paediatric patients with sickle cell disease: An analysis of resource use and costs in a European country. Pediatric Blood & Cancer, 67 (9):e28588. doi:

Thielen, W.F., van Dongen-Leunis, A., Arons, A.M.M., Ladestein, J.R. & Hoogerbrugge, P.R. (2020). Cost‐effectiveness of Anti‐CD19 chimeric antigen receptor T‐Cell therapy in pediatric relapsed/refractory B‐cell acute lymphoblastic leukemia. A societal view. European Journal of Haematology, 105 (2). doi:

Tosetto, A., Badiee, Z., Baghaipour, M.R., Baronciani, L., Battle, J., Berntorp, E., Bodo, I., Budde, U., Castaman, G., Eikenboom, J.C.J., Eshghi, P., Ettorre, C., Goodeve, A., Goudemand, J., Richard, C., Hay, M., Hoorfar, H., Karimi, M., Keikhaei, B., Lassila, R., Leebeek, F.W.G., Fernandez, M.F.L., Mannucci, P., Mazzucconi, M., Morfini, M., Oldenburg, J., Peake, I., Lopez, R.P., Peyvandi, F., Schneppenheim, R., Tiede, A., Toogeh, G., Trossaert, M., Zekavat, O., Zetterberg, E.M.K. & Federici, A. (2020). Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study. Journal of Thrombosis and Haemostasis, 18 (9), 2145-2154. doi:

Turk, Y., Theel, W., Huisstede, A. van, Geijn, G.J.M. van de, Birnie, E., Hiemstra, P.S., Sont, J.K., Taube, C. & Braunstahl, G.J. (2020). Short-term and long-term effect of a high-intensity pulmonary rehabilitation programme in obese patients with asthma: a randomised controlled trial. European Respiratory Journal, 56 (1):1901820. doi:

Veen, K.M., Angst, I.B. de, Mokhles, M.M., Westgeest, H.M., Kuppen, M.C.P., Uyl – de Groot, C.A., Gerritsen, W., Kil, P.J.M. & Takkenberg, J.J.M. (2020). A clinician’s guide for developing a prediction model: a case study using real‑world data of patients with castration‑resistant prostate cancer. Journal of Cancer Research and Clinical Oncology, 146, 2067-2075. doi:

Veldwijk, J., Viberg Johansson, J., Donkers, B. & Bekker – Grob, E.W. de (2020). Mimicking Real-Life Decision Making in Health: Allowing Respondents Time to Think in a Discrete Choice Experiment. Value in Health, 23 (7), 945-952. doi:

Visser, L.A., Louapre, C., Groot, C.A. de & Redekop, W.K. (2020). Patient needs and preferences in relapsing-remitting multiple sclerosis: A systematic review. Multiple Sclerosis and Related Disorders, 39, 101929. doi:

Vullings, I., Labrie, N., Wammes, J., Bekker – Grob, E.W. de & MacNeil-Vroomen, J. (2020). Important components for Dutch in-home care based on qualitative interviews with persons with dementia and informal caregivers. Health Expectations, 23 (6), 1412-1419. doi:

Wester, V.J., Groot, S. de, Kanters, T.A., Wagner, L., Ardesch, J., Corro Ramos, I., Enders-Slegers, M.J., de Ruiter, M., Cessie, S. le, Los, J., Papageorgiou, G., Exel, N.J.A. van & Versteegh, M.M. (2020). Evaluating the Effectiveness and Cost-Effectiveness of Seizure Dogs in Persons With Medically Refractory Epilepsy in the Netherlands: Study Protocol for a Stepped Wedge Randomized Controlled Trial (EPISODE). FRONTIERS IN NEUROLOGY, 11 (3). doi:

Whichello, C.L., Bywall, K., Mauer, J., Watt, S., Cleemput, I., Pinto, C.A., Overbeeke, E. van, Huys, I., Bekker – Grob, E.W. de, Hermann, R. & Veldwijk, J. (2020). An overview of critical decision-points in the medical product lifecycle: Where to include patient preference information in the decision-making process? Health Policy. doi:

Whichello, C.L., Levitan, B., Juhaeri, J., Patadia, V., DiSantostefano, R., Pinto, C.A. & Bekker – Grob, E.W. de (2020). Appraising patient preference methods for decision-making in the medical product lifecycle: an empirical comparison. BMC Medical Informatics and Decision Making, 20:114. doi:

Zemplenyi, A.T., Csikós, A., Csanádi, M., Rutten – van Molken, M.P.M.H., Hernandez, C., Pitter, J.G., Czypionka, T., Kraus, M. & Kaló, Z. (2020). Implementation of Palliative Care Consult Service in Hungary – Integration barriers and facilitators. BMC Palliative Care, 19 (1):41. doi: